Fidelity Investments’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Fidelity Investments's ARKG Position: Q1 2025 in Review
Fidelity Investments sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 7 shares — an estimated $165 sold.
Fidelity Investments first reported a position in ARKG in Q2 2019 and held it in 18 quarters. The position peaked at $20K in Q2 2021. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.
- Fidelity Investments reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
- Fidelity Investments sold 7 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $165.
- Fidelity Investments first reported a position in ARK Genomic Revolution ETF in Q2 2019 and held it in 18 quarters.
- Fidelity Investments's ARK Genomic Revolution ETF position peaked at $20K in Q2 2021.
- 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.
Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.